基本信息
浏览量:158
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr. Muthiah (Mano) Manoharan serves as a Senior Vice President of Drug Innovation, a Scientific Advisory Board Member, and a Distinguished Research Scientist at Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA. In 2003, he was the first chemist hired at Alnylam and built the Drug Discovery team at Alnylam.
研究兴趣
论文共 586 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Current protocolsno. 6 (2024): e1088-e1088
Krishna Ganesh,Muthiah Manoharan
ACS omegano. 20 (2024): 21680-21685
Mikyung Yu,June Qin,Xiumin Liu,Diane Ramsden, Brian Williams,Ivan Zlatev,Dale Guenther,Shigeo Matsuda, Roxanne Tymon,Justin Darcy, Catrina Wong, Jamie Tsung,
NUCLEIC ACIDS RESEARCHno. 10 (2024): 5423-5437
S. Engelbeen,Svetlana Pasteuning-Vuhman, Joke Boertje-van der Meulen,Rubina Parmar,Klaus Charissé,Laura Sepp‐Lorenzino,Muthiah Manoharan,Annemieke Aartsma‐Rus,M. van Putten
Nucleic Acid Therapeuticsno. 1 (2023): 26-34
Shubaash Anthiya,Süleyman Can Öztürk,Hamdullah Yanik,Ece Tavukcuoglu,Adem Şahin,Dhrubajyoti Datta,Klaus Charisse, David Moreira Álvarez,María Isabel Loza,Alfonso Calvo,Einar Sulheim, Simon Loevenich,
Journal of controlled release : official journal of the Controlled Release Society (2023): 67-83
Sarah Engelbeen,Svetlana Pasteuning-Vuhman, Joke Boertje-van der Meulen,Rubina Parmar,Klaus Charisse,Laura Sepp-Lorenzino,Muthiah Manoharan,Annemieke Aartsma-Rus,Maaike van Putten
DRUG METABOLISM REVIEWSno. 4 (2023): 301-342
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn